spacer
home > epc > spring 2009 > asian hotspots
PUBLICATIONS
European Pharmaceutical Contractor

Asian Hotspots

The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and will gradually be eclipsed by ‘footprint growth’ as a key factor shaping decisions. Companies need to set their strategic sights on a future world where Asia is not just a market and manufacturing powerhouse for the pharma industry, but could make a key contribution to drug discoveries as well.

Outsourcing decisions have traditionally been driven by cost factors. However, with the wider global economic balance shifting from west to east, and with the growing importance of end-markets in Asia being matched with increasing Asian pharmaceutical expertise across the value chain, cost is just one of a range of factors that companies need to consider when making outsourcing decisions in Asia.

Increasingly, such decisions need to be informed by strategic as much as tactical considerations. The outsourcing steps that companies make today cannot be divorced from the footprint strides they will need to make over a 10-20 year time period (1). There are four clusters of factors that are relevant to the decisionmaking context faced by multinational pharmaceutical companies when they consider outsourcing in Asian territories (see Figure 1). Increasingly, these factors are also relevant to the outsourcing carried out by fast-growing Asia-based pharmaceutical companies.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Beatrijs Van Liedekerke is Associate Director at PricewaterhouseCoopers China, where she advises the pharmaceutical and biotech industry. With 12 years of industry experience and six years of consulting experience in food, pharma and biotech companies, holding positions in QA/QC, production, R&D and customer relations, Beatrijs has built up expertise in a wide variety of regulatory compliance issues, operational improvement and overall business optimisation. Beatrijs is a Pharmacist with a PhD in pharmaceutical sciences and holds a degree in Business Management.

Sujay J Shetty has over 15 years of industry experience in the pharmaceutical and technology industry in India, the UK and Malaysia. He leads the India Pharmaceutical/Life Sciences Advisory practice of PricewaterhouseCoopers, based in Mumbai. He is a member of the National Pharmaceutical Committee of FICCI for 2008-2009. Prior to joining PricewaterhouseCoopers, he was working with the Corporate Finance practices of UK investment bank Lazard Brothers in London and UB group, Dubai. Sujay is a Chartered Accountant and holds an MBA from the University of Chicago Graduate School of Business, two Masters degrees in Law and Finance from the London School of Economics, and is also attending executive education at Harvard Business School, US.

spacer
Beatrijs Van Liederkerke
spacer
spacer
spacer
Sujay J Shetty
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Senior Vice President Dr. David Daniel Honored in PharmaVOICE 100

Philadelphia, PA – August 1, 2019: Signant Health (formerly CRF Health and Bracket) today announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector. Dr. Daniel was selected from a large cross section of established professionals in the life sciences industry for his passion to continually improve the way in which science, technology and service interact. This honor swiftly follows another recent mark of distinction for Dr. Daniel, having been co-awarded the 2019 ISCDD Scientific Leadership Award.
More info >>

White Papers

Interface: Drug Delivery Devices

Phillips-Medisize

A family is packing for its annual summer trek to the cottage by the lake. Along with fishing gear, sunscreen, and life vests, the checklist also includes another kind of life saver – an autoinjector that delivers two doses of epinephrine to treat anaphylaxis, a severe and potentially lifethreatening allergic reaction.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement